The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
This is an interesting RNS for Bell which came out after market closed on Friday but isn't showing on LSE yet.
https://www.investegate.co.uk/announcement/rns/belluscura--bell/holding-s-in-company/8124172
As a result of this investment Tom W has closed his short & recommended his followers do as well.
Tom's closing comment.
'I am very sceptical about this company after its latest disaster. I would certainly not go long. But do I want to bet against both Britain’s Buffett and also Mr. Magic? On balance no. There are better shorts out there.'
GLA
Tom's closing comment.
'I am very sceptical about this company after its latest disaster. I would certainly not go long. But do I want to bet against both Britain’s Buffett and also Mr. Magic? On balance no. There are better shorts out there.'
GLA
This is an interesting RNS which came out after market closed on Friday but isn't showing here yet.
https://www.investegate.co.uk/announcement/rns/belluscura--bell/holding-s-in-company/8124172
As a result of this investment Tom W has closed his short & recommended his followers do as well.
Might be life in this dog yet.
GLA
RNS today from SA says;
"This conversion means that £0.71m of the £1.6m we drew down for the acquisition of Dermatonics has converted. We appreciate the continued support we have received from the shareholders who have been with us since IPO. We see this as a validation of what we have achieved so far and the ongoing strategy to build scale and financial strength."
What about the remaining £0.89m then, how is that going to be resolved?
I'm not sure Elric that your analysis tonight covers this or provides a balanced view. Easy for you to dismiss TW's comments and observations today but even you must have some concerns over this whole funding saga.
Looking back through the RNS's you can see that Acne study results have slipped from end of Q1 to end of April, so no update until May probably.
No Sales forecasts from UMG as you rightly say and eagerly awaited.
Croda later in the year (hopefully), but who knows when.
When we get dates from SA they are always missed, so he keeps quiet instead.
Lots of unanswered questions IMHO but I'm still here and added to my holding as 2025 can't be any worse than what we have had so far in 2024.
GLA
220 people took part over 56 days (8 weeks), interim results 5 weeks released on 27th Feb so maybe took a week to for them to share which suggests the 8 weeks were up around 15th to 20th March. How long does it take to put a spreadsheet together to share the results? Hopefully by end of Qtr1 was said, well that was missed. let's hope they come out tomorrow then!!
GLA
From the RNS 27th February providing 5 week interim results.
27 February 2024 - SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that interim data from the AxisBiotix Acne food supplement consumer participant study with the lead formulation are very positive. The Company will continue the study to completion. The analysis and read-out of the final results is anticipated to occur before the end of Q1 2024.
Q1 has been and gone and no final results shared so another missed date of over promise, under deliver. When will he learn?
GLA
So Madabout what haven't I understood, please enlighten me.
Quote from the RNS 12th March: Purusant to the two previous conversions announced on 9 February 2024 and 28 February 2024, a total of 1,324,484 Ordinary shares have been converted and sold by Macquarie Bank/CLG which represents 13% of all trading volume in the market during the month of February 2024.
Furthermore, Macquarie Bank/CLG have agreed to no further conversions for the month of March unless price and volumes reach certain agreed higher thresholds.
From RNS 22nd March: At the time of the Dermatonics acquisition, the Convertible Bond Facility was the best option for raising finance; however, now that we have secured an accretive target and thus generate significantly greater revenue the Board now has the possibility of securing alternative, more traditional financing instruments and has come to an amicable agreement with CLG Capital (and by proxy, Macquarie Bank) not to utilise the Facility any further.
You also don't need to get personal, it weakens your argument.
GLA
Now we have entered qtr 2 we can look forward to results on Tuesday 9th, with a dividend to be announced, also the grand opening of the new facility which should bring some new contract wins as well. Not sure of the opening date yet, 2024 looks good to me here.
GLA